BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alard A, Fabre B, Anesia R, Marboeuf C, Pierre P, Susini C, Bousquet C, Pyronnet S. NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome. Mol Cell Biol 2010;30:1097-105. [PMID: 20028737 DOI: 10.1128/MCB.00868-09] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Megarity CF, Timson DJ. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity. Biosci Rep 2019;39:BSR20191874. [PMID: 31431515 DOI: 10.1042/BSR20191874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Ryan A, Wang CJ, Laurieri N, Westwood I, Sim E. Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductases. Protein Cell 2010;1:780-90. [PMID: 21203919 DOI: 10.1007/s13238-010-0090-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
3 Di Francesco A, Choi Y, Bernier M, Zhang Y, Diaz-Ruiz A, Aon MA, Kalafut K, Ehrlich MR, Murt K, Ali A, Pearson KJ, Levan S, Preston JD, Martin-Montalvo A, Martindale JL, Abdelmohsen K, Michel CR, Willmes DM, Henke C, Navas P, Villalba JM, Siegel D, Gorospe M, Fritz K, Biswal S, Ross D, de Cabo R. NQO1 protects obese mice through improvements in glucose and lipid metabolism. NPJ Aging Mech Dis 2020;6:13. [PMID: 33298924 DOI: 10.1038/s41514-020-00051-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Lee WS, Ham W, Kim J. Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases. Life (Basel) 2021;11:1301. [PMID: 34947831 DOI: 10.3390/life11121301] [Reference Citation Analysis]
5 Dinkova-Kostova AT, Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys 2010;501:116-23. [PMID: 20361926 DOI: 10.1016/j.abb.2010.03.019] [Cited by in Crossref: 440] [Cited by in F6Publishing: 417] [Article Influence: 36.7] [Reference Citation Analysis]
6 Zhu L, Barrett EC, Xu Y, Liu Z, Manoharan A, Chen Y. Regulation of Cigarette Smoke (CS)-Induced Autophagy by Nrf2. PLoS One 2013;8:e55695. [PMID: 23585825 DOI: 10.1371/journal.pone.0055695] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
7 Salido E, Timson DJ, Betancor-fernández I, Palomino-morales R, Anoz-carbonell E, Pacheco-garcía JL, Medina M, Pey AL. Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1. JPM 2022;12:747. [DOI: 10.3390/jpm12050747] [Reference Citation Analysis]
8 Alard A, Marboeuf C, Fabre B, Jean C, Martineau Y, Lopez F, Vende P, Poncet D, Schneider RJ, Bousquet C, Pyronnet S. Differential Regulation of the Three Eukaryotic mRNA Translation Initiation Factor (eIF) 4Gs by the Proteasome. Front Genet 2019;10:254. [PMID: 30984242 DOI: 10.3389/fgene.2019.00254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Zhou HZ, Zeng HQ, Yuan D, Ren JH, Cheng ST, Yu HB, Ren F, Wang Q, Qin YP, Huang AL, Chen J. NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma. Cell Commun Signal 2019;17:168. [PMID: 31842909 DOI: 10.1186/s12964-019-0491-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Tsvetkov P, Adler J, Strobelt R, Adamovich Y, Asher G, Reuven N, Shaul Y. NQO1 Binds and Supports SIRT1 Function. Front Pharmacol 2021;12:671929. [PMID: 34234670 DOI: 10.3389/fphar.2021.671929] [Reference Citation Analysis]
11 Kostecka A, Sznarkowska A, Meller K, Acedo P, Shi Y, Mohammad Sakil HA, Kawiak A, Lion M, Królicka A, Wilhelm M, Inga A, Zawacka-Pankau J. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. Cell Death Dis 2014;5:e1484. [PMID: 25341038 DOI: 10.1038/cddis.2014.408] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
12 Hyun DH, Kim J, Moon C, Lim CJ, de Cabo R, Mattson MP. The plasma membrane redox enzyme NQO1 sustains cellular energetics and protects human neuroblastoma cells against metabolic and proteotoxic stress. Age (Dordr) 2012;34:359-70. [PMID: 21487704 DOI: 10.1007/s11357-011-9245-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
13 Preethi S, Arthiga K, Patil AB, Spandana A, Jain V. Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway. Mol Biol Rep 2022. [PMID: 35347544 DOI: 10.1007/s11033-022-07369-2] [Reference Citation Analysis]
14 Yang Y, Zheng J, Wang M, Zhang J, Tian T, Wang Z, Yuan S, Liu L, Zhu P, Gu F, Fu S, Shan Y, Pan Z, Zhou W. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-NRF2 signaling. Cancer Sci 2021;112:641-54. [PMID: 33222332 DOI: 10.1111/cas.14744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Sanchez A, Wadhwani S, Grammas P. Multiple neurotrophic effects of VEGF on cultured neurons. Neuropeptides 2010;44:323-31. [PMID: 20430442 DOI: 10.1016/j.npep.2010.04.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
16 Csizmadia V, Hales P, Tsu C, Ma J, Chen J, Shah P, Fleming P, Senn JJ, Kadambi VJ, Dick L, Wolenski FS. Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi. Toxicol Res (Camb) 2016;5:1619-28. [PMID: 30090462 DOI: 10.1039/c6tx00220j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]